from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0529/ccsA

LFCtreatmentdescriptionclass of inhibitor

-0.237

Amikacinug/mL Amikacintranslation

-0.701

Cap5-10ug/mL Capreomycintranslation

-0.355

Rox10-50 ug/mL Roxithromycintranslation

-0.088

SM2-5 ug/mL Streptomycintranslation

0.554

Tet5-10 ug/mL Tetracyclinetranslation

0.982

Rif0.2-5ug/mL Rifampicintranscription

0.173

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.301

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.494

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.957

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.076

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.381

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.017

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.850

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.018

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.479

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.075

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.050

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.376

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.288

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.843

KCN5-20 ug/mL Potassium cyaniderespiration

-0.380

NaN30.2-2 mM Sodium aziderespiration

-0.853

Nigericin50 uM Nigericinrespiration

-0.601

TRC10-150 ug/mL Triclosanrespiration

-1.559

TRZ10-25 ug/mL Thioridazinerespiration

-0.228

Valinomycin0.5-10 uM Valinomycinrespiration

-1.856

ZnSO42 mM ZnSO4respiration

-0.575

menadione6-10 ug/mL Menadionerespiration

0.161

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.171

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.231

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.746

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.978

NRP_1Non-replicating persistence stage 1dosRassociated

-0.117

Amp0.2mg/mL AmpicillincellWall

-0.260

Cephalexin20-100 ug/mL CephalexincellWall

-0.056

Cerulenin0.32-5 ug/mL CerulenincellWall

0.427

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.835

EMB10-20 ug/mL EthambutolcellWall

0.471

Eta12-40 ug/mL EthionamidecellWall

0.570

INH0.2-0.4 ug/mL IsoniazidcellWall

0.500

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.233

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.793

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.096

BZA0.12 mg/mL BenzamidearomaticAmides

0.049

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.271

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.351

H2O24 mM hydrogen peroxideDNAdamaging

0.438

Levo10 ug/mL LevofloxacinDNAdamaging

0.644

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.457

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.785

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.925

UVUV-irradiationDNAdamaging

-1.220

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.039

Antimycin12.5-50 ug/mL Antimycin A?

-0.163

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.258

PA_110-50 ug/mL Antitubercular compound PA-1?

0.197

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.711

PA8240.2-2 ug/mL PA-824?

0.813

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.107

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.294

Verapamil50 uM Verapamil?

-0.184

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.580

methoxatin10-20 ug/mL Methoxatin?